FXR1 and schizophrenia: Interestingly, anxiety symptoms are highly comorbid in schizophrenia patients and FXR1 being a risk factor for schizophrenia can represent a potential molecular target to study mood related problems in these patients (Braga et al., 2013; Temmingh and Stein, 2015).